Clinical Trials for Affini-T Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Affini-T Therapeutics

Clinical Trials (2)

NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Mar 6, 2024 · Completed: Dec 31, 2029
5 conditions1 sponsor10 locations
NCT06043713
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
PHASE1Active, not recruiting
5 participants
Started: Dec 15, 2023 · Completed: Feb 9, 2026
1 condition2 sponsors1 location